Document is current
Any future updates will be listed below
-
Authors
Hitt, R.
Iglesias, L.
López-Pousa, A.
Berrocal-Jaime, A.
Grau, J. J.
García-Girón, C.
Martínez-Trufero, J.
Guix, M.
Lambea-Sorrosal, J.
del Barco-Morillo, E.
León-Vintró, X.
Cunquero-Tomas, A. J.
Baste, N.
Ocaña, A.
Cruz-Hernández, J. J. https://orcid.org/0000-0003-1980-2751
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00261703 at ClinicalTrials.govDocuments that mention this clinical trial
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial
https://doi.org/10.1007/s12094-020-02467-8
- License Information
-
More Information
Article History
Received: 27 May 2020
Accepted: 23 July 2020
First Online: 14 August 2020
Compliance with ethical standards
:
: R. Hitt has received honoraria for advisory role from Merck. L. Iglesias has received honoraria for advisory role from Merck, Serono, MSD, BMS, Bayer, Sanofi, AstraZeneca, Novartis and Kura Oncology. A. Berrocal-Jaime has received honoraria for advisory role from BMS, MSD, Roche, Novartis, Pierre Fabre, Merck, Pfizer, Sanofi and Incyte. J. Martínez-Trufero has received honoraria for advisory role from Pharmamar, Merck, Lilly, Eisai, BMS and Bayer. J. Lambrea-Sorrosal has received honoraria for advisory role from Merck, Sanofi, MSD and BMS. E. del Barco-Morillo has received honoraria for advisory role from Roche and AstraZeneca. A. J. Cunquero-Tomas has received honoraria for advisory role from Novartis, Roche, Merck, BMS and Pierre-Fabré. N. Baste has received honoraria for advisory role from Merck, Nanobiotics, AstraZeneca, MSD and BMS. J. J. Cruz has received honoraria for advisory role from Merck, BMS, MSD, Roche, Astra Zeneca and Novartis. All remaining authors have declared no conflicts of interest.
: The study was conducted following the local and national regulations (Spanish agency: Agencia Nacional del Medicamento), including the ethical approval of the ethics committee in each hospital and in compliance with the Helsinki declaration.
: All patients received and signed an informed consent following the local and national regulations.
